DaVita Inc. (DVA)

Warren Buffett is one of the most celebrated investors of our time. The famed chief executive officer of Berkshire Hathaway, who will celebrate his 95th birthday on Aug. 30, is finally retiring from t...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

DVA reports strong second-quarter 2025 results with earnings and revenue beat, along with a boost in gross margin, driven by core operations.

DaVita Inc. (NYSE:DVA ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Javier J. Rodriguez - CEO & Executive Director Joel Ackerman - CFO & Treasurer Nic Eliason - Gro...

DaVita HealthCare (DVA) came out with quarterly earnings of $2.95 per share, beating the Zacks Consensus Estimate of $2.7 per share. This compares to earnings of $2.59 per share a year ago.

DaVita beat Wall Street estimates for second-quarter profit on Tuesday, driven by demand for its kidney dialysis services.

DaVita HealthCare (DVA) closed the most recent trading day at $140.37, moving 2.91% from the previous trading session.

DVA rides early momentum from phosphate binders ahead of second-quarter 2025 earnings, but PD supply issues may cloud growth.

DaVita HealthCare (DVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.